天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

化合物 ARN 272,ARN272

化合物 ARN 272|T5357|TargetMol

價(jià)格 125 197 347
包裝 2mg 5mg 10mg
最小起訂量 1mg
發(fā)貨地 上海
更新日期 2024-12-12
QQ交談 微信洽談

產(chǎn)品詳情

中文名稱:化合物 ARN 272英文名稱:ARN272
CAS:488793-85-7品牌: TargetMol
產(chǎn)地: 美國(guó)保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
純度規(guī)格: 98.23%產(chǎn)品類別: 抑制劑
貨號(hào): T5357
2024-12-12 化合物 ARN 272 ARN272 2mg/125RMB;5mg/197RMB;10mg/347RMB 125 TargetMol 美國(guó) Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. 98.23% 抑制劑

Product Introduction

Bioactivity

名稱ARN272
描述ARN272 is a FAAH-like anandamide transporter (FLAT) inhibitor (IC50: 1.8 μM).
動(dòng)物實(shí)驗(yàn)All rats were surgically implanted with intra-oral cannula under isoflurane anaesthesia. Following recovery from surgery (3 days), rats received a single adaptation trial to habituate them to the chamber and the infusion procedure. During the adaptation trial, rats were placed individually in the TR chamber and received a 2?min intra-oral infusion of water (reverse osmosis water infused at 1?mL/min). On the following day, rats received the first of two conditioning trials (separated by 72?h). On each conditioning trial, rats received a pretreatment injection of ARN272 or VEH 120?min prior to the conditioning trials. During conditioning trails, rats were intra-orally infused with a saccharin solution (0.1%) for 2?min (1?mL/min) and orofacial and somatic reactions were recorded on video. Immediately following the saccharin infusion, the rats were injected with LiCl (0.15?M) or saline, and then returned to their home cage. Two additional groups were added (after ARN272 at 3.0?mg·kg?1 attenuated gaping) where pretreatment of ARN272 at 3.0?mg·kg?1 or VEH was given 120?min prior, and with SR141716 30?min prior, to each conditioning trial. The groups were VEH-Saline (VEH-SAL), n = 9; VEH-LiCl, n = 8; 0.1?mg/kg ARN272-LiCl, n = 9; 1.0?mg/kg ARN272-LiCl, n = 8; 3.0?mg/kg ARN272-LiCl, n = 8; 1.0?mg/kg SR-3.0?mg/kg ARN272, n = 8; 1.0?mg/kg SR-VEH, n = 8. Seventy-two hours following the second conditioning trial, the rats received a drug-free TR test. During the TR test, rats were re-exposed to a 2?min intra-oral infusion of saccharin solution and their orofacial and somatic responses again recorded. All video recordings were later scored by a rater blind to the experimental conditions using ‘The Observer'. Following the TR test, the rats were returned to their home cages and at 16:00?h, their water bottles were removed to begin a water deprivation regime in preparation for the CTA test.At 08:00?h the following morning, the rats received a one-bottle test in which a graduated tube of 0.1% saccharin solution was placed on the home cage, and the amount consumed was recorded at 30 and 120?min intervals. A one-bottle test was used as there is evidence to suggest it is more sensitive in detecting between-group differences in strength of taste avoidance than a two-bottle test where both water and saccharin are made available [2].
體外活性ARN272對(duì)FLAT的抑制似乎是選擇性的,因?yàn)檫@種化合物對(duì)幾種內(nèi)源性大麻素代謝酶幾乎沒有或沒有抑制作用。此外,ARN272對(duì)大鼠腦FAAH活性的抑制作用弱且不完全,且在與重組人FAAH-1孵育后不被顯著水解(在37°C下孵育24小時(shí)后的水解率約為5%)[1]。
體內(nèi)活性在小鼠體內(nèi),通過腹腔注射ARN272(1mg/kg)能夠提高血漿中阿納米酰胺(anandamide)的水平,而不影響2-AG、OEA或PEA的水平。研究指出,ARN272抑制阿納米酰胺在體外內(nèi)化和在體內(nèi)失活的效應(yīng),以及在faah-1/ 小鼠中觀察到的阿納米酰胺積聚減少現(xiàn)象[1]。ARN272的系統(tǒng)性給藥在大鼠中產(chǎn)生了劑量依賴性地抑制因惡心引起的條件性張口行為,并在鼩鼱中減少了嘔吐的劑量依賴性降低。在大鼠中,與ARN272(3.0mg/kg)的系統(tǒng)性共同給藥能完全逆轉(zhuǎn)ARN272以1.0mg/kg抑制的張口行為。SR141716單獨(dú)使用的效果與載體溶液無差異[2]。
存儲(chǔ)條件Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
溶解度H2O : Insoluble
Ethanol : 8 mg/mL (18.50 mM)
DMSO : 50 mg/mL (115.61 mM)
關(guān)鍵字ARN-272 | inhibit | Inhibitor | ARN272
相關(guān)產(chǎn)品2-Chlorophenylboronic acid | Carprofen | MM-433593 | JNJ-40355003 | PF 750 | WWL 154 | Dual FAAH/sEH-IN-1 | PDP-EA | AM 374 | VU534 | FAAH inhibitor 1 | Palmitoylisopropylamide
相關(guān)庫(kù)抑制劑庫(kù) | 脂代謝化合物庫(kù) | 經(jīng)典已知活性庫(kù) | 已知活性化合物庫(kù) | 代謝化合物庫(kù) | 神經(jīng)信號(hào)分子庫(kù) | NO PAINS 化合物庫(kù) | 抗肥胖化合物庫(kù) | 抗代謝疾病化合物庫(kù)
關(guān)鍵字: ARN 272|TargetMol

公司簡(jiǎn)介

TargetMol Chemicals Inc. 總部位于馬薩諸塞州波士頓,致力于為全球生化領(lǐng)域科學(xué)家的研究提供專業(yè)的產(chǎn)品和服務(wù)。TargetMol?品牌的客戶群分布于40多個(gè)國(guó)家和地區(qū),已發(fā)展成為全球知名的化合物庫(kù)和小分子化合物研究供應(yīng)商。 TargetMol?可提供160多種滿足不同需求的化合物庫(kù),以及多種類型的生化試劑產(chǎn)品,包括12000多種抑制劑、16000多種天然產(chǎn)物和各類多肽、抗體、生命科學(xué)試劑盒等,此外,我們還建設(shè)有CADD(計(jì)算機(jī)輔助藥物設(shè)計(jì))研究中心、藥理實(shí)驗(yàn)室、藥化合成平臺(tái)三大技術(shù)中心,全方位滿足客戶的定制需求。 憑借我們優(yōu)質(zhì)的產(chǎn)品和服務(wù)、快速高效的全球供應(yīng)鏈和專業(yè)的技術(shù)支持,我們將有效幫助您縮短研發(fā)周期,取得更成功的結(jié)果。
成立日期 2013-04-18 (12年) 注冊(cè)資本 566.265100萬人民幣
員工人數(shù) 100-500人 年?duì)I業(yè)額 ¥ 1億以上
主營(yíng)行業(yè) 天然產(chǎn)物,生化試劑,分子生物學(xué),分子砌塊,生物技術(shù)服務(wù) 經(jīng)營(yíng)模式 貿(mào)易,工廠,試劑,定制,服務(wù)
  • TargetMol中國(guó)(陶術(shù)生物)
VIP 3年
  • 公司成立:12年
  • 注冊(cè)資本:566.265100萬人民幣
  • 企業(yè)類型:有限責(zé)任公司(自然人投資或控股)
  • 主營(yíng)產(chǎn)品:小分子抑制劑、藥物篩選化合物庫(kù)、藥物篩選等
  • 公司地址:靜安區(qū)江場(chǎng)三路238號(hào)8樓
詢盤

化合物 ARN 272|T5357|TargetMol相關(guān)廠家報(bào)價(jià)

產(chǎn)品名稱 價(jià)格   公司名稱 報(bào)價(jià)日期
詢價(jià)
VIP3年
湖北??怂股邢薰?/div>
2024-12-02
詢價(jià)
VIP5年
陜西締都醫(yī)藥化工有限公司
2024-12-18
詢價(jià)
VIP3年
陜西締都醫(yī)藥化工有限公司
2024-12-18
¥1499.90
VIP1年
上海阿拉丁生化科技股份有限公司
2024-11-29
內(nèi)容聲明:
以上所展示的信息由商家自行提供,內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由發(fā)布商家負(fù)責(zé)。 商家發(fā)布價(jià)格指該商品的參考價(jià)格,并非原價(jià),該價(jià)格可能隨著市場(chǎng)變化,或是由于您購(gòu)買數(shù)量不同或所選規(guī)格不同而發(fā)生變化。最終成交價(jià)格,請(qǐng)咨詢商家,以實(shí)際成交價(jià)格為準(zhǔn)。請(qǐng)意識(shí)到互聯(lián)網(wǎng)交易中的風(fēng)險(xiǎn)是客觀存在的